Texas Oncology PA - Bedford

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia1 trial
• Head and neck cancer1 trial
• Myeloproliferative neoplasms1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Radiation Therapy Oncology Group2 trials
• Novartis Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

  NCT05456191· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

  NCT00956007· Phase 3· Radiation Therapy Oncology Group· Source

Closed trials

• Completed

  Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

  NCT01546987· Phase 3· Radiation Therapy Oncology Group· Source